This oxidative stress arising from the excessive energy and material demands of cancer cells is mainly counteracted via activation of the nuclear factor erythroid 2-related factor 2 (NRF2) pathway, a master regulator of the cellular antioxidant response [3, 4]. The gene discussed is NFE2L2; the disease is cancer.